These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 8932544

  • 1. Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma.
    Northfelt DW, Martin FJ, Working P, Volberding PA, Russell J, Newman M, Amantea MA, Kaplan LD.
    J Clin Pharmacol; 1996 Jan; 36(1):55-63. PubMed ID: 8932544
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.
    Northfelt DW, Dezube BJ, Thommes JA, Miller BJ, Fischl MA, Friedman-Kien A, Kaplan LD, Du Mond C, Mamelok RD, Henry DH.
    J Clin Oncol; 1998 Jul; 16(7):2445-51. PubMed ID: 9667262
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma.
    Cooley T, Henry D, Tonda M, Sun S, O'Connell M, Rackoff W.
    Oncologist; 2007 Jan; 12(1):114-23. PubMed ID: 17227906
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group.
    Goebel FD, Goldstein D, Goos M, Jablonowski H, Stewart JS.
    Br J Cancer; 1996 Apr; 73(8):989-94. PubMed ID: 8611437
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.
    Gill PS, Wernz J, Scadden DT, Cohen P, Mukwaya GM, von Roenn JH, Jacobs M, Kempin S, Silverberg I, Gonzales G, Rarick MU, Myers AM, Shepherd F, Sawka C, Pike MC, Ross ME.
    J Clin Oncol; 1996 Aug; 14(8):2353-64. PubMed ID: 8708728
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
    Cheung TW, Remick SC, Azarnia N, Proper JA, Barrueco JR, Dezube BJ.
    Clin Cancer Res; 1999 Nov; 5(11):3432-7. PubMed ID: 10589755
    [Abstract] [Full Text] [Related]

  • 15. FDA approves KS drug. Food and Drug Administration. Florida Department of Health and Rehabilitation Services.
    AIDS Alert; 1996 Jan; 11(1):11-2. PubMed ID: 11363227
    [Abstract] [Full Text] [Related]

  • 16. Development of liposomal anthracyclines: from basics to clinical applications.
    Gabizon A, Goren D, Cohen R, Barenholz Y.
    J Control Release; 1998 Apr 30; 53(1-3):275-9. PubMed ID: 9741935
    [Abstract] [Full Text] [Related]

  • 17. Psoriasiform pustular eruptions from pegylated-liposomal doxorubicin in AIDS-related Kaposi's sarcoma.
    Kreuter A, Gambichler T, Schlottmann R, Altmeyer P, Brockmeyer N.
    Acta Derm Venereol; 2001 Apr 30; 81(3):224. PubMed ID: 11558892
    [No Abstract] [Full Text] [Related]

  • 18. Liposomal doxorubicin for treatment of AIDS-related Kaposi's sarcoma.
    Simpson JK, Miller RF, Spittle MF.
    Clin Oncol (R Coll Radiol); 1993 Apr 30; 5(6):372-4. PubMed ID: 8305358
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.